Hanson & Doremus Investment Management »

Takeda Pharmaceutical shares owned by Hanson & Doremus Investment Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Hanson & Doremus Investment Management from 13F filings

Historical chart of Hanson & Doremus Investment Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Hanson & Doremus Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Hanson & Doremus Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 1.0k 14.00
2019-06-30 $10k 557 17.95
2019-03-31 $21k 1.0k 20.73

More positions owned by Hanson & Doremus Investment Management

Schwab U.S. Broad Market ETF Etf (SCHB)
Vanguard Intermediate Treasury ETF Etf (VGIT)
Vanguard Developed Market ETF Etf (VEA)
Vanguard Intermediate Corporate ETF Etf (VCIT)
Vanguard ESG US Stock ETF Etf (ESGV)
Vanguard Emerging Market ETF Etf (VWO)
Microsoft Common (MSFT)
Vanguard ESG International Stock ETF Etf (VSGX)
Schwab Int'l Equity ETF Etf (SCHF)
Taiwan Semiconductor Adr (TSM)
Charles Schwab Corp. Common (SCHW)
Costco Common (COST)
Vanguard ESG US Corporate Bond ETF Etf (VCEB)
Berkshire Hathaway Cl B Common (BRK.B)
Merck Common (MRK)

View all positions for Hanson & Doremus Investment Management

Top funds holding Takeda Pharmaceutical

Mondrian Investment Partners
Morgan Stanley
Goldman Sachs Group
Brandes Investment Partners
FMR
Millennium Management
BlackRock
Northern Trust
Citadel Advisors
Van Eck Associates Corp.
Managed Asset Portfolios
Envestnet Asset Management
Bank of America Corporation
Causeway Capital Management
Arrowstreet Capital, Limited Partnership

View all funds holding Takeda Pharmaceutical